Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP618368.RASXIslXbUZm-nK8_rNFkd3Cs1gB1TmU3G4svoMX7XwS8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP618368.RASXIslXbUZm-nK8_rNFkd3Cs1gB1TmU3G4svoMX7XwS8130_assertion type Assertion NP618368.RASXIslXbUZm-nK8_rNFkd3Cs1gB1TmU3G4svoMX7XwS8130_head.
- NP618368.RASXIslXbUZm-nK8_rNFkd3Cs1gB1TmU3G4svoMX7XwS8130_assertion description "[Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618368.RASXIslXbUZm-nK8_rNFkd3Cs1gB1TmU3G4svoMX7XwS8130_provenance.
- NP618368.RASXIslXbUZm-nK8_rNFkd3Cs1gB1TmU3G4svoMX7XwS8130_assertion evidence source_evidence_literature NP618368.RASXIslXbUZm-nK8_rNFkd3Cs1gB1TmU3G4svoMX7XwS8130_provenance.
- NP618368.RASXIslXbUZm-nK8_rNFkd3Cs1gB1TmU3G4svoMX7XwS8130_assertion SIO_000772 17609426 NP618368.RASXIslXbUZm-nK8_rNFkd3Cs1gB1TmU3G4svoMX7XwS8130_provenance.
- NP618368.RASXIslXbUZm-nK8_rNFkd3Cs1gB1TmU3G4svoMX7XwS8130_assertion wasDerivedFrom befree-2016 NP618368.RASXIslXbUZm-nK8_rNFkd3Cs1gB1TmU3G4svoMX7XwS8130_provenance.
- NP618368.RASXIslXbUZm-nK8_rNFkd3Cs1gB1TmU3G4svoMX7XwS8130_assertion wasGeneratedBy ECO_0000203 NP618368.RASXIslXbUZm-nK8_rNFkd3Cs1gB1TmU3G4svoMX7XwS8130_provenance.